Desynchronosis is also known as Jet lag, and happens to people who travel frequently across different time zones. it is a physiological condition occurs due to disruption in the body's circadian rhythms. It can cause headaches, insomnia, and irritability.
MARKET SCOPE
The "Global Desynchronosis Treatment Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the desynchronosis treatment market with detailed market segmentation by drug class, distribution channel, and geography. The report provides key statistics on the market status of the leading desynchronosis treatment market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on drug class, the global desynchronosis treatment market is segmented into prescription drugs, and OTC drugs. Based on prescription drugs, the market is further sub segmented into non-benzodiazepines, and benzodiazepines. Based on OTC drugs, the market is further sub segmented into diphenhydramine, doxylamine, melatonin, and herbal and natural products.
- On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, online sales.
Drivers-
- Increasing number of air travelers.
- Growing adoption of advanced treatment technology including wearable and portable light therapy devices.
- Rise in international tourism.
- Drug abuse and addiction
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The desynchronosis treatment market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the desynchronosis treatment market in these regions.
IMPACT OF COVID-19 ON DESYNCHRONOSIS TREATMENT MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Tourism and hospitality businesses have been profoundly affected by COVID-19. International tourism has been highly affected due to travel bans on account of growing cases. Therefore, the COVID-19 has negatively impacted the growth if the desynchronosis treatment market.
MARKET PLAYERS
The report covers key developments in the Desynchronosis Treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Desynchronosis Treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for Desynchronosis Treatment in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the desynchronosis treatment market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Clinigen Group plc
- Vanda Pharmaceuticals Inc
- Pfizer Inc
- Jamieson Laboratories Ltd
- NOW Foods
- Nature's Bounty
- ALEXZA
- Jazz Pharmaceuticals, Inc
- Eisai Co., Ltd
- Purdue Pharma L.P